Demant A/S: Financiel calendar 2025
Company announcement no 2024-16 4 December 2024
Financial calendar 2025
|
22 January |
Deadline for submission of items for the agenda of the annual |
|
15 January to 4 February
|
Quiet period prior to publication of Annual Report 2024 |
|
5 February
|
Annual Report 2024 |
|
6 March
|
Annual general meeting |
|
16 April to 6 May
|
Quiet period prior to publication of Interim Management Statement |
|
6 May
|
Interim Management Statement for Q1 2025 |
|
23 July to 12 August
|
Quiet period prior to publication of Interim Report 2025 |
|
12 August
|
Interim Report 2025 |
|
15 October to 4 November
|
Quiet period prior to publication of Interim Management Statement |
|
4 November
|
Interim Management Statement for Q3 2025 |
* Please note that if a shareholder would like to have a specific item included in the agenda for the annual general meeting on 6 March 2025, a written proposal must be submitted to the Board of Directors no later than six weeks prior to the annual general meeting, which means that proposals must reach the Board of Directors no later than 22 January 2025.
|
Further information: Peter Pudselykke, Head of Investor Relations Phone +45 2830 7638 |
Contacts
Henrik Axel Lynge Buchter
External Communication Manager
Corporate Communication & Sustainability
Tel:
About Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.
Alternative languages
Attachments
Subscribe to our company announcements
Keep up to date with our company announcements by subscribing.
Visit our pressroom and see more company announcements from us.
Our pressroom